Orgenesis (ORGS) Peer Comparison
$0.03
$-1.92
(-98.32%)
As on 27-Aug-2026 16:00EDT
Market cap
$1 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Edit
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
1 | 12,753 | 12,153 | 10,906 | 10,222 |
Revenue ($ Mln) |
1 | 1,505 | 6,164 | 613 | 785 |
Net Profit ($ Mln) |
-48.17 | 160.59 | 625.00 | -188.05 | 41.54 |
Net Margin (%) |
-- | 10.67 | 5.41 | -30.68 | 5.29 |
RoE (%) |
164.71 | 10.86 | 11.84 | -28.10 | 1.97 |
Price to Earnings |
-- | 79.35 | 19.89 | -- | 251.57 |
Price-To-Book |
1.26 | 8.41 | 2.37 | 16.38 | 4.84 |
Income Statement ($ Mln)
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1.04 | 1,194.62 | 5,810.00 | 383.48 | 634.44 |
|
Cost of Revenue
|
9.51 | 439.62 | 1,731.00 | 94.03 | 359.79 |
|
Gross Profit
|
-8.47 | 755.00 | 4,079.00 | 289.45 | 274.65 |
|
Operating Expenses
|
27.10 | 668.77 | 3,422.00 | 411.82 | 309.76 |
|
Operating Profit (EBIT)
|
-26.07 | 86.22 | 657.00 | -122.37 | -35.11 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-48.92 | 20.87 | 498.00 | -145.60 | -27.04 |
|
Provision for Tax
|
-- | 6.86 | 86.00 | 0.77 | -1.52 |
|
Profit after Tax (Net Income)
|
-48.17 | 14.01 | 412.00 | -146.37 | -25.51 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 14.01 | 412.00 | -- | -- |
Liabilities ($ Mln)
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-37.50 | 1,150.93 | 5,265.00 | 766.93 | 1,972.72 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
11.96 | 223.91 | 3,558.00 | 132.70 | 730.16 |
|
Current Liabilities
|
26.92 | 158.35 | 1,531.00 | 75.13 | 126.79 |
|
Total Liabilities
|
1.35 | 1,533.18 | 10,354.00 | 974.76 | 2,829.67 |
Assets ($ Mln)
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.59 | 582.06 | 5,933.00 | 524.96 | 1,763.63 |
|
Current Assets
|
0.76 | 951.13 | 4,421.00 | 449.79 | 1,066.04 |
|
Total Assets
|
-- | 1,533.18 | 10,354.00 | 974.76 | 2,829.67 |
|
Total Debt*
|
-- | 223.39 | 3,321.00 | 103.40 | 686.25 |
|
Net Current Assets
|
-26.16 | 792.78 | 2,890.00 | 374.67 | 939.25 |
Cashflow ($ Mln)
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-17.08 | 168.48 | 987.00 | -61.32 | 175.39 |
|
Cash Flow from Investing Activities
|
-- | 77.62 | -569.00 | 47.83 | -86.38 |
|
Cash from Financing Activities
|
15.96 | -87.01 | -86.00 | 91.54 | -82.90 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
268.61 | 1.01 | 4.88 | -17.06 | -0.96 |
|
ROE (%)
|
164.71 | 1.20 | 7.86 | -23.83 | -1.29 |
|
ROA (%)
|
-605.73 | 0.91 | 4.05 | -15.29 | -0.90 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-4,653.62 | 1.17 | 7.09 | -38.17 | -4.02 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.95 | 0.13 | 0.05 | 0.22 | -0.01 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
13.00 | -84.59 | 56.65 | -8.70 | -161.37 |
|
EPS Growth (%)
|
-4.33 | -0.85 | 2.11 | 0.04 | -1.61 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | 665.53 | 26.24 | -56.94 | -316.25 |
|
Price / Book Value
|
-- | 8.10 | 2.05 | 10.87 | 4.09 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | 200.24 | 10.12 | -84.89 | 99.32 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 0.19 | 0.63 | 0.13 | 0.35 |
|
Short term debt to equity ratio
|
-- | 0.01 | 0.01 | 0.00 | 0.01 |
|
Current Ratio
|
0.03 | 6.01 | 2.89 | 5.99 | 8.41 |
|
Quick Ratio
|
0.03 | 3.44 | 1.33 | 5.22 | 7.28 |
|
Interest Coverage
|
-- | 15.72 | 5.90 | -13.50 | -0.28 |
Operating Efficiency Ratios
| Orgenesis (ORGS) | Penumbra (PEN) | Smith & Nephew SNATS - ADR | Glaukos Corp (GKOS) | Repligen (RGEN) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
3.86 | 14.04 | 20.77 | 15.84 | 21.14 |
|
Asset Turnover
|
0.13 | 0.77 | 0.57 | 0.40 | 0.22 |
|
Receivable days
|
459.30 | 56.48 | 71.23 | 47.91 | 74.35 |
|
Inventory Days
|
0.65 | 330.16 | 504.51 | 193.57 | 175.26 |
|
Payable days
|
326.79 | 24.29 | 221.34 | 51.40 | 26.24 |
|
Cash Conversion Cycle
|
133.16 | 362.34 | 354.40 | 190.08 | 223.37 |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
